Latest

MEDIA ADVISORY: June 7, 2007 Contact: Gabriel Sayegh, 646-335-2264 or Tony Newman, 646-335-5384 Rockefeller Drug Law Reform Advocates to Throw a Surprise Birthday Party on Friday at Noon for Gov. Eliot Spitzer Real Reform New York Coalition and Others to Deliver Birthday Cake and Card to Spitzer Asking Him to Keep His Campaign Promise to Reform Draconian Drug Laws New York, NY—The Real Reform New York Coalition will join with many others on Friday, June 8 at noon to throw a surprise birthday party for Gov. Eliot Spitzer outside of his New York City office. Asking him to heed his campaign promise to reform the draconian Rockefeller drug laws, the coalition will celebrate Spitzer’s promise of justice. The Real Reform New York Coalition, made up of advocates, people formerly incarcerated under the Rockefeller drug laws, their family members and supporters, will share cake and party favors with the crowd, and deliver a large birthday card—signed by New York voters—demanding real reform of the Rockefeller Drug Laws. While campaigning, Spitzer promised to make Rockefeller Drug Law reform a priority during his term as governor. However, during the first six months in office, he has remained strangely silent about reforming Rockefeller Drug Laws. The Rockefeller drug laws underwent minor changes in 2004 and 2005. These changes proved to be ineffective in changing the racist and non-rehabilitative impact of these laws. The Rockefeller drug laws have filled New York’s state prisons with more than 14,000 people convicted of drug offenses, representing nearly 38 percent of the prison population and costing New Yorkers more than $550 million annually. New York’s Drug Law Reform Act of 2004 (DLRA) lowered some drug sentences but it fell far short of allowing most people serving under the more punitive sentences to apply for shorter terms. The reforms also did not increase the power of judges to place addicts into treatment programs. While advocates and family members are encouraged by the modest reforms, they maintain that the recent reforms have no impact on the majority of people behind bars. Most people behind bars on Rockefeller drug law violations are charged with nonviolent lower-level or class-B felonies. In April, the state Assembly passed A.6663, a bill that would significantly reform the Rockefeller Drug Laws by expanding treatment, reducing harsh sentences for low-level offenses, and increasing judicial discretion. Governor Spitzer has yet to comment on the bill, which is now sitting in the Senate. What: Surprise Birthday Party/Rally for Rockefeller Drug Law Reform Where: Outside Gov. Spitzer’s New York City Office, 633 3rd Ave. When: Friday, June 8, 2007, 12 p.m. to 2 p.m.

For Immediate Release: June 6, 2007 For More Info: Bill Piper (202) 669-6430 or Naomi Long (202) 669-6071 Rep. Tiahrt (R-Kan.) Continues to Make Uninformed Statements That Discount the Proven Effectiveness of Needle Exchange Programs Advocates to Deliver Mountain of Evidence to Tiahrt’s Office Today So the Kansas Congressman Can Stop Embarrassing Himself Despite Washington, D.C. having one of the worst HIV infection rates in the country, Rep. Todd Tiahrt (R-Kan.) continues to ignore the mountain of scientific evidence that proves the effectiveness of syringe exchange programs at reducing the transmission of HIV/AIDS, hepatits C and other infectious disease. Tiahrt’s assertion that there are no proven studies that show the efficacy syringe exchange programs is a direct effort to sabotage a recent Congressional effort to remove the ban on funding syringe exchange programs in Washington, D.C. In a strong editorial in today’s Washington Post calling for D.C. to be allowed to fund needle exchange programs, Tiahrt is quoted claiming “…needle exchange programs have been proven in many studies to be ineffective and a threat to the surrounding community, especially the children.” In response, the Drug Policy Alliance will hand deliver numerous studies proving the effectiveness of needle exchange programs to Tiahrt’s office today. “Rep. Tiahrt’s claims that syringe exchange programs don’t work is similar to claiming the world is flat,” said Bill Piper, national affairs director of the Drug Policy Alliance. “We want him to have the information so he doesn’t continue to embarrass himself and, more importantly, sabotage this life-saving measure.” Every established medical, scientific, and legal body to study the issue concurs in the efficacy of improved access to sterile syringes to reduce the spread of infectious diseases: including the National Academy of Sciences, American Medical Association, American Public Health Association, Centers for Disease Control and Prevention, and President George H.W. Bush's and President Clinton's AIDS Advisory Commissions. Eight government reports concur that access to sterile syringes deceases the transmission of infectious diseases without increasing drug use. No reports contradict these findings. On Tuesday, June 5, Congress moved one step closer to lifting the funding ban on syringe exchange programs in Washington, D.C. The House Subcommittee on Financial Services and General Government removed the ban from an appropriations bill that includes the city’s spending plan. In 1998, Tiahrt and the Republican-led Congress barred the D.C. government from spending its own local funds on syringe exchange programs. The ban was reauthorized in the appropriations bill every year since. But with Democrats now in power, the push to lift the ban gained traction. Rep. Jose Serrano (D-NY), who chairs the committee, spearheaded the effort to lift the ban. It has been long established by the scientific community that needle exchange programs reduce the spread of HIV/AIDS amongst people who inject drugs without increasing drug use. In Washington, D.C., injecting drugs is the second-most common means of contracting HIV among men—and the most common form among women. Approximately one-third of new AIDS cases annually are the result of intravenous drug use. DC’s syringe exchange program is crucial to getting people with substance abuse problems into drug treatment. The program estimates it refers about 50 people a month to treatment. Needle exchange programs help public health professionals assess the medical needs of clients, gain trust in the community by meeting clients in their own surroundings, and provide educational materials and referrals.

For immediate release: June 5, 2007 For More Information Contact: John Walsh, Senior Associate, (202) 797-2171, ext 203; cell (202) 213-4863 or Roger Atwood, Communications Director, (202) 797-2171, ext 211; cell (202) 316-3857 New Estimates Show Coca Rising in Colombia, Despite Record Year for Fumigation The U.S. government reported Monday that the amount of land in Colombia under cultivation with coca, the raw material for cocaine, increased 9 percent in 2006 over the previous year. The area under coca cultivation reached 388,000 acres in 2006, up 32,600 acres from 2005, based on figures released by the White House Office of National Drug Control Policy (ONDCP). WOLA, the research and advocacy group, believes these figures offer fresh and disturbing evidence that the U.S.-backed policy of aerial herbicide spraying of coca fields – a practice known as fumigation – is failing to curb coca production. On the contrary, fumigation is prompting farmers to replant as quickly and in as many locations as they can, contributing to the dispersal of coca growing and Colombia’s internal armed conflict to new areas of the country. “Rather than weaken farmers’ reliance on coca, fumigation serves to reinforce it,” said WOLA Senior Associate John Walsh. “To insist at this point that more spraying will somehow deter farmers from replanting is not just unrealistic, it’s delusional.” The report of a rise in coca cultivation followed another record-setting year of fumigation, with 425,000 acres sprayed, nearly 25 percent more than in 2005. Since 2000 the U.S.-backed program has sprayed herbicide on some 2.1 million acres in Colombia. U.S. and Colombian authorities should focus resources on rural development, alternative livelihoods, and on-the-ground destruction of illegal coca plantations and end the wrong-headed, counterproductive focus on fumigation. ### The Washington Office on Latin America is a non-governmental organization that promotes human rights, democracy, and social and economic justice in U.S. policy towards Latin America.

FOR IMMEDIATE RELEASE: June 5, 2007 CONTACT: Naomi Long, (202) 669-6071 or Bill Piper, (202) 669-6430 Clean Syringe Funding Ban for District of Colombia Lifted Rep. Serrano Removes Provision Prohibiting Tax Payer Money Going to D.C. Syringe Exchange Programs Today Congress moved to lift the funding ban on syringe exchange programs in Washington, DC. The House Subcommittee on Financial Services and General Government removed the ban from an appropriations bill that includes the city’s spending plan. In 1998, the Republican-led Congress barred the District Government from spending its own local funds on syringe exchange programs. The ban has been reauthorized in the appropriations bill every year since. But with Democrats now in power, the push to lift the ban gained traction. Rep. Jose Serrano (D-NY), who chairs the committee, spearheaded the effort to lift the ban. “This is a huge step in helping to reduce HIV and AIDS in Washington, DC,” said Naomi Long, director of the Washington Metro office for the Drug Policy Alliance. “We are pleased that Congress decided to stop playing politics with the lives of intravenous drug users in D.C.” It has been long established by the scientific community that needle exchange programs reduce the spread of HIV/AIDS amongst people who inject drugs without increasing drug use. In Washington, DC, injecting drugs is the second-most common means of contracting HIV among men - and the most common form among women. Approximately one-third of new AIDS cases annually are the result of intravenous drug use. Supporters of needle exchange include the American Medical Association, American Public Health Association, Centers for Disease Control and three former U.S. Surgeons General. A number of faith communities officially support needle exchange including The Presbyterian Church (USA), Episcopal Church and the United Church of Christ.